CIK 0001819790 · Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 814717861
- Phone
- (949) 409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,192,759
- in 6 filings, $5.2M under 10b5-1 plans
Net −$5,192,759. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-04 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −7,100 | $90.27 | $641K | 830,891 |
| 2026-09-04 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −2,900 | $91.27 | $265K | 827,991 |
| 2026-09-02 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −10,000 | $80.06 | $801K | 837,991 |
| 2026-06-17 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −4,582 | $61.24 | $281K | 853,409 |
| 2026-06-17 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −5,418 | $61.81 | $335K | 847,991 |
| 2026-03-19 | Azamian Bobak R. President/CEO and Board Chair | Sale | −11,964 | $67.00 | $802K | 33,421 |
| 2026-03-18 | Azamian Bobak R. President/CEO and Board Chair | Sale | −11,667 | $68.71 | $802K | 45,385 |
| 2026-03-17 | Azamian Bobak R. President/CEO and Board Chair | Sale | −10,972 | $69.42 | $762K | 57,052 |
| 2026-03-15 | Azamian Bobak R. President/CEO and Board Chair | Option exercise | +66,274 | 68,024 | ||
| 2026-03-15 | Azamian Bobak R. President/CEO and Board Chair | Option exercise · Restricted Stock Units | −11,300 | 0 | ||
| 2026-03-15 | Azamian Bobak R. President/CEO and Board Chair | Option exercise · Restricted Stock Units | −16,975 | 16,975 | ||
| 2026-03-15 | Azamian Bobak R. President/CEO and Board Chair | Option exercise · Restricted Stock Units | −23,121 | 46,243 | ||
| 2026-03-15 | Azamian Bobak R. President/CEO and Board Chair | Option exercise · Restricted Stock Units | −14,878 | 44,634 | ||
| 2026-03-05 | Azamian Bobak R. President/CEO and Board Chair | Grant or award · Stock Option (right to buy) | +96,723 | 96,723 | ||
| 2026-03-05 | Azamian Bobak R. President/CEO and Board Chair | Grant or award · Restricted Stock Units | +60,776 | 60,776 | ||
| 2025-12-24 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −5,443 | $82.41 | $449K | 858,548 |
| 2025-12-24 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −557 | $83.54 | $47K | 857,991 |
| 2025-12-04 | Azamian Bobak R. President/CEO and Board Chair | Gift | −51,885 | 1,750 | ||
| 2025-09-24 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −6,000 | $55.37 | $332K | 812,106 |
| 2025-08-11 | Azamian Bobak R. President/CEO and Board Chair | Sale 10b5-1 | −6,000 | $50.00 | $300K | 818,106 |
Page 1 of 2 · 30 trades